Browse > Article
http://dx.doi.org/10.5999/aps.2016.43.6.523

The Effect of Sterile Acellular Dermal Matrix Use on Complication Rates in Implant-Based Immediate Breast Reconstructions  

Lee, Jun Ho (Department of Plastic and Reconstructive Surgery, Yeungnam University College of Medicine)
Park, Youngsoo (Department of Plastic and Reconstructive Surgery, Yeungnam University College of Medicine)
Choi, Kyoung Wook (Department of Plastic and Reconstructive Surgery, Yeungnam University College of Medicine)
Chung, Kyu-Jin (Department of Plastic and Reconstructive Surgery, Yeungnam University College of Medicine)
Kim, Tae Gon (Department of Plastic and Reconstructive Surgery, Yeungnam University College of Medicine)
Kim, Yong-Ha (Department of Plastic and Reconstructive Surgery, Yeungnam University College of Medicine)
Publication Information
Archives of Plastic Surgery / v.43, no.6, 2016 , pp. 523-528 More about this Journal
Abstract
Background The use of acellular dermal matrix (ADM) in implant-based immediate breast reconstruction has been increasing. The current ADMs available for breast reconstruction are offered as aseptic or sterile. No published studies have compared aseptic and sterile ADM in implant-based immediate breast reconstruction. The authors performed a retrospective study to evaluate the outcomes of aseptic versus sterile ADM in implant-based immediate breast reconstruction. Methods Implant-based immediate breast reconstructions with ADM conducted between April 2013 and January 2016 were included. The patients were divided into 2 groups: the aseptic ADM (AlloDerm) group and the sterile ADM (MegaDerm) group. Archived records were reviewed for demographic data and postoperative complication types and frequencies. The complications included were infection, flap necrosis, capsular contracture, seroma, hematoma, and explantation for any cause. Results Twenty patients were reconstructed with aseptic ADM, and 68 patients with sterile ADM. Rates of infection (15.0% vs. 10.3%), flap necrosis (5.0% vs. 7.4%), capsular contracture (20.0% vs. 14.7%), seroma (10.0% vs. 14.7%), hematoma (0% vs. 1.5%), and explantation (10.0% vs. 8.8%) were not significantly different in the 2 groups. Conclusions Sterile ADM did not provide better results regarding infectious complications than aseptic ADM in implant-based immediate breast reconstruction.
Keywords
Breast implants; Acellular dermis; Mammaplasty;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Venturi ML, Mesbahi AN, Boehmler JH 4th, et al. Evaluating sterile human acellular dermal matrix in immediate expander-based breast reconstruction: a multicenter, prospective, cohort study. Plast Reconstr Surg 2013;131:9e-18e.   DOI
2 Breuing KH, Warren SM. Immediate bilateral breast reconstruction with implants and inferolateral AlloDerm slings. Ann Plast Surg 2005;55:232-9.   DOI
3 Liu AS, Kao HK, Reish RG, et al. Postoperative complications in prosthesis-based breast reconstruction using acellular dermal matrix. Plast Reconstr Surg 2011;127:1755-62.   DOI
4 Antony AK, McCarthy CM, Cordeiro PG, et al. Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications. Plast Reconstr Surg 2010;125:1606-14.   DOI
5 Lanier ST, Wang ED, Chen JJ, et al. The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction. Ann Plast Surg 2010;64:674-8.
6 Nahabedian MY. AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation. Plast Reconstr Surg 2009;124:1743-53.   DOI
7 Vardanian AJ, Clayton JL, Roostaeian J, et al. Comparison of implant-based immediate breast reconstruction with and without acellular dermal matrix. Plast Reconstr Surg 2011;128:403e-410e.   DOI
8 Yuen JC, Yue CJ, Erickson SW, et al. Comparison between freeze-dried and ready-to-use AlloDerm in alloplastic breast reconstruction. Plast Reconstr Surg Glob Open 2014;2:e119.   DOI
9 Lee JH, Kim HG, Lee WJ. Characterization and tissue incorporation of cross-linked human acellular dermal matrix. Biomaterials 2015;44:195-205.   DOI
10 Salzberg CA. Direct-to-implant breast reconstruction. Clin Plast Surg 2012;39:119-26.   DOI
11 Chun YS, Verma K, Rosen H, et al. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg 2010;125:429-36.   DOI
12 JoAnna Nguyen T, Carey JN, Wong AK. Use of human acellular dermal matrix in implant- based breast reconstruction: evaluating the evidence. J Plast Reconstr Aesthet Surg 2011;64:1553-61.   DOI
13 Spear SL, Pelletiere CV, Lockwood M. Immediate breast reconstruction with tissue expanders and AlloDerm. In: Spear SL, Willey SC, Robb GL, et al., editors. Surgery of the breast: principles and art. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p.484-8.
14 United States Pharmacopeial Convention. 1211: Sterility testing. United States Pharmacopeia and National Formulary (USP25-NF20). Rockville: United States Pharmacopeial Convention; 2002.
15 Weichman KE, Wilson SC, Saadeh PB, et al. Sterile "ready-to-use" AlloDerm decreases postoperative infectious complications in patients undergoing immediate implant-based breast reconstruction with acellular dermal matrix. Plast Reconstr Surg 2013;132:725-36.   DOI
16 Centers for Disease Control and Prevention (CDC). Update: allograft-associated bacterial infections: United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:207-10.
17 Losken A. Early results using sterilized acellular human dermis (Neoform) in post-mastectomy tissue expander breast reconstruction. Plast Reconstr Surg 2009;123:1654-8.   DOI
18 Buseman J, Wong L, Kemper P, et al. Comparison of sterile versus nonsterile acellular dermal matrices for breast reconstruction. Ann Plast Surg 2013;70:497-9.   DOI